Rhythm Pharmaceuticals (RYTM) PT Increased From $136 to $143 at Wells Fargo on IMCIVREE Launch Optimism
RhythmRhythm(US:RYTM) Yahoo Finance·2026-03-19 05:16

We recently compiled a list of the Top 10 Boring Stocks That Make Money. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is one of the most boring stocks that make money. TheFly reported on March 12 that Wells Fargo increased its price target for RYTM to $143 from $136 while keeping an Overweight rating on the stock. The update reflects slightly higher revenue projections and greater confidence in the launch of IMCIVREE for hypothalamic obesity. Discussions with physicians treating early patient populations po ...

Rhythm Pharmaceuticals (RYTM) PT Increased From $136 to $143 at Wells Fargo on IMCIVREE Launch Optimism - Reportify